The economic burden of hypertension

Amelie F. Constant*, Eleni V. Geladari, Charalampia V. Geladari

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Abstract

Hypertension or abnormally high blood pressure is a serious and stealth condition that leads to heart attack, stroke and renal diseases. It has become a major and growing public health problem worldwide that requires an integrated approach. Even worse, the increase in the incidence of hypertension is expected to continue, with the disease manifesting a grave impact on the quality of life of hypertensive patients and their families, as well as on mortality and morbidity. As a result, this epidemiological trend generates great costs in medical care, making the need for financial resource allocation and health care system capacity planning imperative. Expenses to treat hypertension especially in countries with public health care systems can easily drain the public coffers. In this chapter we aim to assess the costs and financial consequences of hypertension worldwide.
Original languageEnglish
Title of host publicationHypertension and Cardiovascular Disease
PublisherSpringer International Publishing
Pages351-359
Number of pages9
ISBN (Electronic)9783319395999
ISBN (Print)9783319395975
DOIs
Publication statusPublished - 1 Jan 2016

Keywords

  • Cost
  • Cost-effectiveness
  • GDP
  • Hospitalizations
  • Hypertension
  • Inpatient
  • Outpatient
  • Policy-makers
  • Primary care
  • Public health care

Fingerprint

Dive into the research topics of 'The economic burden of hypertension'. Together they form a unique fingerprint.

Cite this